Related Experiment Video
Updated: Jan 25, 2026

Seven Steps to Stellate Cells
Published on: May 10, 2011
Mannose Phosphate Isomerase and Mannose Regulate Hepatic Stellate Cell Activation and Fibrosis in Zebrafish and
Charles DeRossi1, Kathryn Bambino2, Joshua Morrison1
1Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY.
Abstract:
The growing burden of liver fibrosis and lack of effective antifibrotic therapies highlight the need for identification of pathways and complementary model systems of hepatic fibrosis. A rare, monogenic disorder in which children with mutations in mannose phosphate isomerase (MPI) develop liver fibrosis led us to explore the function of MPI and mannose metabolism in liver development and adult liver diseases. Herein, analyses of transcriptomic data from three human liver cohorts demonstrate that MPI gene expression is down-regulated proportionate to fibrosis in chronic liver diseases, including nonalcoholic fatty liver disease and hepatitis B virus. Depletion of MPI in zebrafish liver in vivo and in human hepatic stellate cell (HSC) lines in culture activates fibrotic responses, indicating that loss of MPI promotes HSC activation. We further demonstrate that mannose supplementation can attenuate HSC activation, leading to reduced fibrogenic activation in zebrafish, culture-activated HSCs, and in ethanol-activated HSCs. Conclusion: These data indicate the prospect that modulation of mannose metabolism pathways could reduce HSC activation and improve hepatic fibrosis.
Insights
Mannose phosphate isomerase (MPI) deficiency causes liver fibrosis. Mannose supplementation can reduce liver fibrosis by inhibiting hepatic stellate cell activation, offering a potential therapeutic strategy.
Area of Science:
- Biochemistry
- Hepatology
- Molecular Biology
Background:
- Liver fibrosis is a significant health concern with limited treatment options.
- A rare genetic disorder linked to mannose phosphate isomerase (MPI) mutations causes liver fibrosis in children.
- Understanding MPI's role in liver health is crucial for developing new therapies.
Purpose of the Study:
- To investigate the function of MPI and mannose metabolism in liver development and disease.
- To explore MPI's role in chronic liver diseases and hepatic fibrosis.
- To assess the therapeutic potential of modulating mannose metabolism.
Main Methods:
- Analysis of transcriptomic data from human liver cohorts.
- MPI depletion in zebrafish liver and human hepatic stellate cell (HSC) lines.
- Assessment of fibrotic responses and HSC activation.
- Mannose supplementation in various models of liver fibrosis.
Main Results:
- MPI gene expression is decreased proportionally to fibrosis severity in chronic liver diseases.
- MPI depletion in vivo and in vitro activates fibrotic responses and promotes HSC activation.
- Mannose supplementation effectively reduces HSC activation and fibrotic markers in multiple models.
Conclusions:
- Loss of MPI function promotes hepatic stellate cell activation and liver fibrosis.
- Modulating mannose metabolism pathways presents a promising therapeutic approach for liver fibrosis.
- Mannose supplementation could be a viable strategy to reduce HSC activation and improve liver fibrosis outcomes.
Related Concept Videos
GTPases and their Regulation
Large G-proteins,...
Enteric Nervous System: Regulation of GI Motor Activity
During periods of fasting, the ENS initiates the migrating myoelectric complex, a...
pH Regulation in Cells
Cytosolic pH
Under physiological conditions, the cytosolic pH is slightly more acidic than the extracellular pH. However, cells must prevent further acidification of their cytosol to...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Phosphate Buffer
Sodium dihydrogen phosphate does not fully dissociate in neutral or acidic solutions. When a strong base, such as sodium hydroxide (NaOH), is introduced into the solution, sodium dihydrogen phosphate...
GPCRs Regulate Adenylyl Cylase Activity

